Delivery Order SPE2DB22D2005-SPE2DB25FJGN5

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,243.04 firm fixed-price delivery order contract is for the supply of Erythromycin 0.5% eye ointment to support military healthcare programs. The contract has an ultimate completion date of September 29, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,165.24 firm fixed-price delivery order is for the supply of 4566688683 - Erythromycin 0.5% Eye Ointment, 3.5 gm. The contract has a completion date of December 12, 2024 and was awarded on December 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Erythromycin 0.5% eye ointment to the Defense Logistics Agency (DLA). The $1,777.58 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of December 13, 2022 and was awarded on December 12, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,188.80 firm fixed price delivery order is for the supply of 4565427156 - Erythromycin 0.5% Eye Ointment 3.5GM, with a completion date of August 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,183.25 Firm Fixed Price Delivery Order is for the supply of Erythromycin 0.5% eye ointment. The contract has an ultimate completion date of September 10, 2024. This award is a task order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,875.41 firm fixed-price delivery order is for the supply of 4564713422 - Erythromycin 0.5% Eye Ointment, 3.5 gm. The award has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,536.33 Firm Fixed Price delivery order is for the supply of Erythromycin 0.5% eye ointment. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. The IDC, which runs through November 2026, serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,681.38 firm fixed-price delivery order is for the supply of 4562316837 ! ERYTHROMYCIN 0.5% EYE OINTMENT 3.5GM. The contract has an ultimate completion date of September 27, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves...
This federal contract award, valued at $1,139.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Erythromycin 0.5% eye ointment 3.5 grams and has an ultimate completion date of December 28, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., also known as Amerisourcebergen....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,119.93 firm fixed price delivery order is for the supply of Erythromycin 0.5% Eye Ointment 3.5GM to support military treatment programs and facilities. The award has a performance period through March 18, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJGN5
    Delivery Order

This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,374.00 Firm Fixed Price Delivery Order is for the supply of Erythromycin 0.5% eye ointment. The contract has an ultimate completion date of January 17, 2025.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award, which does not have a set-aside designation, is likely part of that broader IDC supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/18/25, 2:11 AM